An interventional study of Visual Pedagogy and Manual Toothbrushing in Autism Spectrum Disorder, Child and Oral Health, sponsored by University of Sao Paulo. Not yet recruiting at 1 site in Brazil. Open to participants aged 5 Years to 13 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-08.
Sponsored by University of Sao Paulo · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 11 studies in Autism Spectrum Disorder with a site in Brazil — 3 open to participants now, 3 under way, none of them phase 3. Autism Spectrum Disorder · Brazil.
Among the 11 studies in Autism Spectrum Disorder with a site in Brazil, this one is the 8th largest by planned enrollment of the 10 interventional ones that give a count, is one of 2 that started in 2025, is one of 6 with no phase, and was the 10th registered.
1,733 studies on the registry are indexed under Autism Spectrum Disorder; 503 are open to participants now.
Browse Autism Spectrum Disorder studies →3 of the 11 studies in Autism Spectrum Disorder with a site in Brazil are open now. Recruiting first, the newest first:
Luiz Alexandre Viana Magno · Sites in Brazil
Ages 6–10
Federal University of Minas Gerais · Sites in Brazil
Ages 12–18
A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →
Of the 351 Autism Spectrum Disorder studies recruiting now, 48 (14%) set no upper age limit and 296 (84%) stop at 75 or younger; 301 take children under 18; 92 take healthy volunteers.
This study: 5 Years to 13 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
11 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 1 · Phase 3 3 · Phase 4 1
First in 2014; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 50 is close to the median of 52 across 1,374 interventional studies indexed under Autism Spectrum Disorder.
Median enrollment 68 across the 10 interventional studies, 55 across the 1 observational. Of the 8 that completed or were terminated, 1 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 11 has an industry lead sponsor. The 9 most frequent:
University of Sao Paulo is the lead sponsor of 1,036 studies on the registry; 96 are open to participants now.
Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
University of Sao Paulo has 2 studies filed under Autism Spectrum Disorder — fewer than ten, so there is no comparison to draw.
1 of the studies in Autism Spectrum Disorder with a site in Brazil that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07322640Luiz Alexandre Viana MagnoPlay Therapy With Gamified Biofeedback in Children With Autism Spectrum Disorder | 2026-12-31 |
Add it to your calendar (.ics) → With an account.
Among the 11 studies in Autism Spectrum Disorder with a site in Brazil, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This randomized clinical trial evaluates the effectiveness of an AI-enabled electric toothbrush and visual pedagogy materials in improving oral hygiene among children with autism spectrum disorder (ASD). The study compares plaque control, gingival health, and adherence between children using a manual toothbrush with visual pedagogy support and those using an AI-enabled electric toothbrush with app-based monitoring.
: Children with autism spectrum disorder (ASD) often face behavioral, motor, and sensory challenges that compromise their ability to perform effective toothbrushing. Caregivers are typically responsible for daily oral hygiene, yet few accessible digital or AI-based tools exist to support this process.
This study addresses this gap by combining two innovative approaches: visual pedagogy resources (picture exchange communication cards and tactile sensory panels) and an AI-enabled electric toothbrush with app-based monitoring. A randomized, parallel clinical trial will be conducted at the School of Dentistry of Ribeirão Preto, University of São Paulo (FORP-USP), including 60 children aged 6-12 years with ASD. Participants will be randomized into two groups:
Inclusion Criteria:Children aged 5-13 years with a prior diagnosis of autism spectrum disorder (ASD) level 1 , 2 or 3 confirmed by a neuropediatrician.
Child must be accompanied by a primary caregiver (≥18 years old) responsible for daily oral hygiene.
Caregiver must have access to a smartphone or computer to interact with the digital platform.
Written (TCLE) from the caregiver and assent (TALE) from the child.
-
Exclusion Criteria:Severe systemic medical conditions that contraindicate participation in clinical oral evaluations.
Children with advanced periodontal disease or other oral conditions requiring urgent dental treatment.
Caregivers who are unable or unwilling to use basic digital platforms (smartphone, tablet, or computer).
Families who decline participation at any stage of the study.
-
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will use a manual toothbrush with caregiver support. Visual pedagogy materials will be provided, including printed picture exchange communication system (PECS) cards illustrating each step of toothbrushing and tactile sensory panels simulating toothbrush bristles, toothpaste texture, and dental floss. Caregivers will be instructed to use these materials daily to improve comprehension and adherence to toothbrushing routines.
Behavioral: Visual Pedagogy and Manual Toothbrushing
Participants will use an Oral-B Genius X electric toothbrush equipped with artificial intelligence and Bluetooth connectivity. The device monitors brushing time, sequence, and pressure, providing real-time feedback through a smartphone application. Caregivers will be trained to supervise and encourage daily use at home for 3 weeks. The intervention aims to improve plaque removal and promote autonomy and motivation during oral hygiene in children with ASD.
Behavioral: Visual Pedagogy and Manual Toothbrushing
Participants in this arm will use a manual toothbrush with caregiver support. Visual pedagogy resources will include printed PECS cards illustrating each step of toothbrushing and tactile sensory panels simulating toothbrush bristles, toothpaste texture, and dental floss. Caregivers will be instructed to use these materials daily at home for 3 weeks to improve comprehension, adherence, and cooperation in children with ASD.
Also known as: Visual support materials, Picture Exchange Communication System (PECS), tactile sensory panels
Change in Plaque Index (Simplified Oral Hygiene Index - Greene & Vermillion)
Difference in gingival health between baseline and follow-up, assessed using the Löe and Silness Gingival Index. Higher scores indicate worse gingival condition.
Time frame: Baseline, Week 3, Week 6
Bleeding on Probing (Community Periodontal Index)
Assessment of bleeding on probing at six index teeth sites, following WHO Community Periodontal Index criteria.
Time frame: Baseline, Week 6
Caregiver-Reported Adherence and Motivation
Questionnaire responses evaluating caregiver perceptions of the child's motivation, autonomy, and adherence to oral hygiene routines.
Time frame: Baseline, Week 6
Usability of Digital Platform (System Usability Scale - SUS)
Usability and acceptability of the caregiver support digital platform, assessed by the 10-item System Usability Scale (SUS). Scores range from 0 to 100; scores above 68 indicate good usability.
Time frame: After 3 weeks of use
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Oct 2025; primary completion for Aug 2026, 10 months later.
Of 806 non-industry interventional studies with no phase under Autism Spectrum Disorder, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's planned 10 months is below that.
Counting every sponsor, half of 829 studies reached it within 25 months; a quarter within 12 and three quarters within 47.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.